Rani Therapeutics Holdings Inc (RANI) Financials

$0.85

$0.00 (-0.33%)

As on 18-Sep-2026 13:30EDT

Market cap

$118 Mln

Revenue (TTM)

$5 Mln

P/E Ratio

--

P/B Ratio

2.4

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	4.88	1.63	1.03	--	--	2.72
Cost of Revenue	0.57	0.90	--	0.82	1.31	--
Gross Profit	4.49	0.73	1.03	-0.82	-1.31	2.72
Operating Expenses	37.68	39.04	54.34	65.28	63.45	54.32
Operating Profit (EBIT)	-32.96	-38.31	-53.31	-66.10	-63.45	-51.60
Other Income	--	--	--	--	1.25	--
Profit before Tax	-33.42	-40.95	-30.02	-67.88	-63.27	-53.05
Provision for Tax	--	--	26.57	-33.91	0.07	0.04
Profit after Tax (Net Income)	-30.14	-29.67	-30.02	-33.97	-30.59	-8.33
Minority Interest	3.28	11.28	26.57	35.51	-32.76	44.76
Consolidated Profit	--	--	--	--	-61.18	-8.33

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	39.23	33.01	1.99	12.87	36.86	47.41
Minority Interest	3.28	--	--	--	37.15	--
Non-Current Liabilities	2.22	4.44	13.25	24.48	29.21	0.00
Current Liabilities	10.64	12.67	19.89	7.99	4.82	2.64
Total Liabilities	71.48	58.62	36.63	57.92	108.03	124.21

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	4.32	5.30	6.89	7.07	7.10	4.61
Current Assets	56.52	53.32	29.74	50.85	100.92	119.60
Total Assets	71.48	58.62	36.63	57.92	108.03	124.21
Total Debt*	3.55	4.32	29.71	30.10	30.21	--
Net Current Assets	45.89	40.65	9.85	42.86	96.11	116.96

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-18.71	-35.50	-51.24	-46.52	-32.25
Cash Flow from Investing Activities	--	-7.03	19.81	29.86	-72.44	-0.51
Cash from Financing Activities	--	40.30	13.59	0.23	29.01	77.15
Net Cash Inflow / Outflow	--	--	--	--	-89.95	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-0.30	-0.20	-0.92	-1.31	-1.23	-0.43
Cash EPS ($)	--	-0.20	-0.89	-1.28	-1.21	-0.40
Adjusted Book Value ($)	--	0.22	0.06	0.50	1.48	2.44
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.13	-1.09	-1.98	-1.87	-1.66
Free Cash Flow per Share ($)	--	-0.13	-1.10	-2.03	-1.93	-1.68

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-85.97	-80.41	-61.74	-53.44	26.81
ROE (%)	-74.35	-169.55	-404.07	-136.64	-72.60	25.27
ROA (%)	-55.30	-62.30	-63.50	-40.94	-26.34	-8.18
EBIT Margin (%)	-488.89	-2,330.62	-5,014.69	--	--	-1,935.26
Net Margin (%)	-618.02	-1,817.09	-2,920.04	--	-2,450.96	-306.62
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	306.42	0.59	--	--	-1.00	4.88
EBIT Growth (%)	50.46	26.17	17.91	-0.96	-18.30	-217.83
Net Profit Growth (%)	-285.56	1.15	11.63	-11.06	-267.16	50.12
EPS Growth (%)	67.38	0.78	0.30	-0.07	-1.87	0.52
Book Value Growth (%)	237.40	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-6.69	-1.49	-2.53	-4.80	-38.15
Price / Book Value	2.42	6.02	22.46	6.68	3.99	6.70
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-1.42	-4.12	-0.93	-1.09	-1.28	-3.85
Close Price ($)	0.76	1.35	1.37	3.32	5.90	16.35
High Price ($)	3.87	3.87	8.75	6.98	27.13	36.27
Low Price ($)	0.39	0.39	1.30	1.82	5.11	9.24
Market Cap ($ Cr)	118.40	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.13	14.91	2.34	0.82	--
Short term debt to equity ratio	0.03	0.05	8.26	0.44	0.03	--
Current Ratio	5.31	4.21	1.50	6.36	20.96	45.30
Quick Ratio	5.31	--	--	--	--	--
Interest Coverage	-27.62	-13.16	-10.24	-12.35	-58.08	-112.83

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	45.38	125.05	41.63	--	--	--
Asset Turnover	0.09	0.03	0.02	--	--	0.03
Receivable days	--	276.23	111.56	--	--	231.22
Inventory Days	--	--	--	--	--	--
Payable days	--	338.47	--	468.34	353.56	--
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.